Copyright Reports & Markets. All rights reserved.

Global Oncology Ablation Sales Market Report 2018 by Manufacturer, Region, Type and Application

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Oncology Ablation Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Radiofrequency Ablation Market Performance (Volume)
      • 2.1.2 Microwave Ablation Market Performance (Volume)
      • 2.1.3 Cryoablation Market Performance (Volume)
      • 2.1.4 Ethanol Ablation Market Performance (Volume)
      • 2.1.5 Irreversible Electroporesis (IRE) Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 Radiofrequency Ablation Market Performance (Value)
      • 2.1.2 Microwave Ablation Market Performance (Value)
      • 2.1.3 Cryoablation Market Performance (Value)
      • 2.1.4 Ethanol Ablation Market Performance (Value)
      • 2.1.5 Irreversible Electroporesis (IRE) Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Hospitals Market Performance (Volume)
      • 3.1.2 Clinical laboratories Market Performance (Volume)
      • 3.1.3 Academic and Research Institutes Market Performance (Volume)
      • 3.1.4 Others Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Accuray Inc.
      • 4.1.1 Accuray Inc. Profiles
      • 4.1.2 Accuray Inc. Product Information
      • 4.1.3 Accuray Inc. Oncology Ablation Business Performance
      • 4.1.4 Accuray Inc. Oncology Ablation Business Development and Market Status
    • 4.2 AngioDynamics
      • 4.2.1 AngioDynamics Profiles
      • 4.2.2 AngioDynamics Product Information
      • 4.2.3 AngioDynamics Oncology Ablation Business Performance
      • 4.2.4 AngioDynamics Oncology Ablation Business Development and Market Status
    • 4.3 APRO KOREA
      • 4.3.1 APRO KOREA Profiles
      • 4.3.2 APRO KOREA Product Information
      • 4.3.3 APRO KOREA Oncology Ablation Business Performance
      • 4.3.4 APRO KOREA Oncology Ablation Business Development and Market Status
    • 4.4 Boston Scientific
      • 4.4.1 Boston Scientific Profiles
      • 4.4.2 Boston Scientific Product Information
      • 4.4.3 Boston Scientific Oncology Ablation Business Performance
      • 4.4.4 Boston Scientific Oncology Ablation Business Development and Market Status
    • 4.5 BSD Medical
      • 4.5.1 BSD Medical Profiles
      • 4.5.2 BSD Medical Product Information
      • 4.5.3 BSD Medical Oncology Ablation Business Performance
      • 4.5.4 BSD Medical Oncology Ablation Business Development and Market Status
    • 4.6 Celon AG (Olympus)
      • 4.6.1 Celon AG (Olympus) Profiles
      • 4.6.2 Celon AG (Olympus) Product Information
      • 4.6.3 Celon AG (Olympus) Oncology Ablation Business Performance
      • 4.6.4 Celon AG (Olympus) Oncology Ablation Business Development and Market Status
    • 4.7 Covidien
      • 4.7.1 Covidien Profiles
      • 4.7.2 Covidien Product Information
      • 4.7.3 Covidien Oncology Ablation Business Performance
      • 4.7.4 Covidien Oncology Ablation Business Development and Market Status
    • 4.8 Elekta AB
      • 4.8.1 Elekta AB Profiles
      • 4.8.2 Elekta AB Product Information
      • 4.8.3 Elekta AB Oncology Ablation Business Performance
      • 4.8.4 Elekta AB Oncology Ablation Business Development and Market Status
    • 4.9 Galil Medical
      • 4.9.1 Galil Medical Profiles
      • 4.9.2 Galil Medical Product Information
      • 4.9.3 Galil Medical Oncology Ablation Business Performance
      • 4.9.4 Galil Medical Oncology Ablation Business Development and Market Status
    • 4.10 HealthTronics Inc.
      • 4.10.1 HealthTronics Inc. Profiles
      • 4.10.2 HealthTronics Inc. Product Information
      • 4.10.3 HealthTronics Inc. Oncology Ablation Business Performance
      • 4.10.4 HealthTronics Inc. Oncology Ablation Business Development and Market Status
    • 4.11 MedWaves Incorporated
    • 4.12 Misonix
    • 4.13 APRO KOREA
    • 4.14 Boston Scientific
    • 4.15 BSD Medical

    5 Market Performance for Manufacturers

    • 5.1 Global Oncology Ablation Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 Global Oncology Ablation Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 Global Oncology Ablation Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 Global Oncology Ablation Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 China Market Performance for Manufacturers
      • 6.1.1 China Oncology Ablation Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 China Oncology Ablation Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 China Oncology Ablation Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 China Oncology Ablation Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 USA Market Performance for Manufacturers
      • 6.2.1 USA Oncology Ablation Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 USA Oncology Ablation Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 USA Oncology Ablation Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 USA Oncology Ablation Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 Europe Market Performance for Manufacturers
      • 6.3.1 Europe Oncology Ablation Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 Europe Oncology Ablation Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 Europe Oncology Ablation Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 Europe Oncology Ablation Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 Japan Market Performance for Manufacturers
      • 6.4.1 Japan Oncology Ablation Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 Japan Oncology Ablation Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 Japan Oncology Ablation Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 Japan Oncology Ablation Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration
    • 6.5 Korea Market Performance for Manufacturers
      • 6.5.1 Korea Oncology Ablation Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.5.2 Korea Oncology Ablation Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.5.3 Korea Oncology Ablation Price (USD/Unit) of Manufacturers 2013-2018
      • 6.5.4 Korea Oncology Ablation Gross Margin of Manufacturers 2013-2018
      • 6.5.5 Market Concentration
    • 6.6 India Market Performance for Manufacturers
      • 6.6.1 India Oncology Ablation Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.6.2 India Oncology Ablation Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.6.3 India Oncology Ablation Price (USD/Unit) of Manufacturers 2013-2018
      • 6.6.4 India Oncology Ablation Gross Margin of Manufacturers 2013-2018
      • 6.6.5 Market Concentration
    • 6.7 Southeast Asia Market Performance for Manufacturers
      • 6.7.1 Southeast Asia Oncology Ablation Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.7.2 Southeast Asia Oncology Ablation Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.7.3 Southeast Asia Oncology Ablation Price (USD/Unit) of Manufacturers 2013-2018
      • 6.7.4 Southeast Asia Oncology Ablation Gross Margin of Manufacturers 2013-2018
      • 6.7.5 Market Concentration
    • 6.8 South America Market Performance for Manufacturers
      • 6.8.1 South America Oncology Ablation Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.8.2 South America Oncology Ablation Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.8.3 South America Oncology Ablation Price (USD/Unit) of Manufacturers 2013-2018
      • 6.8.4 South America Oncology Ablation Gross Margin of Manufacturers 2013-2018
      • 6.8.5 Market Concentration

    7 Global Oncology Ablation Market Performance (Sales Point)

    • 7.1 Global Oncology Ablation Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 Global Oncology Ablation Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 Global Oncology Ablation Price (USD/Unit) by Regions 2013-2018
    • 7.4 Global Oncology Ablation Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 Global Oncology Ablation Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 China Oncology Ablation Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 USA Oncology Ablation Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 Europe Oncology Ablation Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 Japan Oncology Ablation Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.6 Korea Oncology Ablation Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.7 India Oncology Ablation Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Southeast Asia Oncology Ablation Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Southeast Asia Oncology Ablation Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Hospitals Industry
    • 11.2 Clinical laboratories Industry
    • 11.3 Academic and Research Institutes Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 Global Oncology Ablation Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 Global Oncology Ablation Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 China Oncology Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 USA Oncology Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 Europe Oncology Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 Japan Oncology Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 Korea Oncology Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 India Oncology Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Southeast Asia Oncology Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.10 South America Oncology Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 Radiofrequency Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 Microwave Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.4 Cryoablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.5 Ethanol Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 Hospitals Sales and and Growth Rate 2019-2024
      • 12.4.3 Clinical laboratories Sales and and Growth Rate 2019-2024
      • 12.4.4 Academic and Research Institutes Sales and and Growth Rate 2019-2024
      • 12.4.5 Others Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 Global Oncology Ablation Price (USD/Unit) Trend 2019-2024
      • 12.5.2 Global Oncology Ablation Gross Profit Trend 2019-2024

    13 Conclusion

    Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Oncology Ablation for these regions, from 2012 to 2023 (forecast), covering
    China
    USA
    Europe
    Japan
    Korea
    India

    Global Oncology Ablation market competition by top manufacturers/players, with Oncology Ablation sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
    Accuray Inc.
    AngioDynamics
    APRO KOREA
    Boston Scientific
    BSD Medical
    Celon AG (Olympus)
    Covidien
    Elekta AB
    Galil Medical
    HealthTronics Inc.
    MedWaves Incorporated
    Misonix
    NeuWave Medical
    RF Medical Co. Ltd
    SonaCare Medical
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Radiofrequency Ablation
    Microwave Ablation
    Cryoablation
    Ethanol Ablation
    Irreversible Electroporesis (IRE)
    Light (Laser Ablation)
    ? ? Ultrasound
    ? ? Others
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Oncology Ablation for each application, including
    Hospitals
    Clinical laboratories
    Academic and Research Institutes
    Others

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now